Search

Search Constraints

You searched for: Author/Creator De Fraipont, Florence

Search Results

1. BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients. Issue 11 (24th November 2020)

2. Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1−)‐pDC subset negatively correlated with clinical outcomes in melanoma patients. Issue 5 (3rd May 2022)

3. Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Issue 11 (9th November 2021)

4. Intravenous Injection of Clinical Grade Human MSCs after Experimental Stroke: Functional Benefit and Microvascular Effect. Issue 12 (December 2016)

6. The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome. (3rd August 2019)

7. T‐cell receptor diversity as a prognostic biomarker in melanoma patients. (3rd February 2020)